Our Products
(855) 338-8800
Cardiac monitoring advancements are transforming clinical trials—enhancing data collection and delivery to improve efficiency and accuracy in clinical trials.
Discover the highlights from our fireside chat with leading experts.
Todd Rudo, MD
EVP, Chief Medical Officer
Mark Matson
Senior Director, Sensor Cloud
David E. Albert, MD
Founder, Chief Medical Officer
Recent FDA guidance on digital health technologies and decentralized trials has influenced the greater adoption and implementation of advanced ECG monitoring in clinical research. Explore how patient-centered monitoring advancements support these trial models, delivering real-time data opportunities and optimizing workflows.
When it comes to data, more is more. Learn how these evolving trial models deliver data that supports advanced AI , streamline data science, and ultimately lead to better outcomes.
AI is revolutionizing the accuracy and efficiency of data analysis in clinical trials. Explore how AI -powered ECG technologies are enhancing data quality and streamlining operations.
QT determinations are essential in clinical trials, but collecting them is challenging. Discover how the 6-lead device alleviates these challenges for more flexible and patient-centric trials.
PharmExec.com | Decentralized trials are known to have positive effects, but sponsors have concerns about how to monitor patients well. Remote patient monitoring (RPM) solutions, like those from AliveCor, are changing this paradigm. The benefits that decentralized trials offer patients and sponsors are evident. Yet, decentralized trials are still lacking.
At a QTc interval threshold of 500 milliseconds, the 6-lead device had a high negative predictive value of 99.8% and was an effective triage test. This validation is pivotal for sponsors aiming to deliver quality data while alleviating common cardiac monitoring challenges.